Clinical Trial Update: Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 [Phase 3]

View source ↗

Summary

Phase III study comparing immunogenicity of a 9-valent HPV recombinant vaccine with Gardasil-9; status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Genital Warts
• Papillomavirus Infections
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• 9-valent HPV recombinant vaccine
• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Shanghai Zerun Biotechnology Co.,Ltd | Conditions: Cervical Cancer, Genital Wart | Phase 3 | Status: UNKNOWN